AR016681A1 - Deplecion de celulas th2; composiciones; metodos - Google Patents
Deplecion de celulas th2; composiciones; metodosInfo
- Publication number
- AR016681A1 AR016681A1 ARP980105731A ARP980105731A AR016681A1 AR 016681 A1 AR016681 A1 AR 016681A1 AR P980105731 A ARP980105731 A AR P980105731A AR P980105731 A ARP980105731 A AR P980105731A AR 016681 A1 AR016681 A1 AR 016681A1
- Authority
- AR
- Argentina
- Prior art keywords
- cells
- compositions
- depection
- methods
- ccr8
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporcionan composiciones de union que se unen selectivamente a un marcador específicamente encontrado en las células Th2 y varios métodos de uso delas composiciones de union. En particular, el método hace uso del hecho que el receptor CCR8 dequ emoquina se expresa selectivamente en el subconjunto decélulas Th2. Preferentemente, la composicion de union es un anticuerpo monoclonal específico para CCR8.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6539297P | 1997-11-13 | 1997-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016681A1 true AR016681A1 (es) | 2001-07-25 |
Family
ID=22062409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105731A AR016681A1 (es) | 1997-11-13 | 1998-11-12 | Deplecion de celulas th2; composiciones; metodos |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1030865A2 (es) |
JP (1) | JP2001523446A (es) |
AR (1) | AR016681A1 (es) |
AU (1) | AU1373099A (es) |
CA (1) | CA2309761A1 (es) |
WO (1) | WO1999025734A2 (es) |
ZA (1) | ZA9810371B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416954B1 (en) * | 1999-02-08 | 2002-07-09 | Schering Corporation | Modulating Th2 cell levels via vMIP-I/CCR8 interaction |
US6762341B2 (en) | 2000-02-10 | 2004-07-13 | Schering Corporation | Uses of mammalian CCR8 receptors and related reagents |
AU2001236802A1 (en) * | 2000-02-10 | 2001-08-20 | Schering Corporation | Novel uses of mammalian ccr8 receptors and related reagents |
WO2003096020A2 (en) * | 2002-05-13 | 2003-11-20 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) |
WO2007044756A2 (en) * | 2005-10-11 | 2007-04-19 | Icos Corporation | Monoclonal antibodies recognizing human ccr8 |
WO2014082993A2 (en) * | 2012-11-30 | 2014-06-05 | Galapagos Nv | Molecular targets and compounds, and methods to identify the same, useful in the down-regulation of the th2 response |
CN109715653A (zh) * | 2016-05-16 | 2019-05-03 | 驰科迈博有限责任公司 | 肿瘤浸润调节性t细胞中被选择性地去调节的标志物 |
MX2021007576A (es) * | 2018-12-27 | 2021-08-24 | Shionogi & Co | Nuevo anticuerpo anti receptor 8 de motivo c-c de quimiocina (ccr8). |
CA3169451A1 (en) | 2020-02-14 | 2021-08-19 | Jounce Therapeutics, Inc. | Antibodies and fusion proteins that bind to ccr8 and uses thereof |
WO2023219147A1 (ja) * | 2022-05-13 | 2023-11-16 | 塩野義製薬株式会社 | Ccr8検出用新規抗ccr8抗体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4364932A (en) * | 1979-09-18 | 1982-12-21 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same |
JP2000508226A (ja) * | 1995-07-21 | 2000-07-04 | アプライド リサーチ システムズ アース ホールディング エヌ.ヴィ. | Lag−3タンパク質によるth1リンパ球を検出、同定、単離並びに選択的に標識およびターゲッティングする方法 |
US6040426A (en) * | 1996-06-05 | 2000-03-21 | Bml, Inc. | Human Th2 specific protein |
-
1998
- 1998-11-12 ZA ZA9810371A patent/ZA9810371B/xx unknown
- 1998-11-12 CA CA002309761A patent/CA2309761A1/en not_active Abandoned
- 1998-11-12 EP EP98957483A patent/EP1030865A2/en not_active Withdrawn
- 1998-11-12 AR ARP980105731A patent/AR016681A1/es unknown
- 1998-11-12 AU AU13730/99A patent/AU1373099A/en not_active Abandoned
- 1998-11-12 WO PCT/US1998/023240 patent/WO1999025734A2/en not_active Application Discontinuation
- 1998-11-12 JP JP2000521113A patent/JP2001523446A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2309761A1 (en) | 1999-05-27 |
ZA9810371B (en) | 1999-08-30 |
WO1999025734A3 (en) | 1999-07-15 |
EP1030865A2 (en) | 2000-08-30 |
WO1999025734A2 (en) | 1999-05-27 |
JP2001523446A (ja) | 2001-11-27 |
AU1373099A (en) | 1999-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2010001209A1 (es) | Anticuerpos monoclonales aislados que preferentemente se unen al polipeptido ca 125/o772p asociado a celulas en relacion al polipeptido ca 125/o772p soluble; hibridoma; acido nucleico que los codifica; composicion farmaceutica; kit polipeptido de fusion; y su uso para preparar un medicamento para tratar un desorden celular proliferativo (divisional de sol. n° 2086-03). | |
BRPI0510716A (pt) | uso de um agente de ligação bi-especìfico, agente de ligação bi-especìfico, composição de um agente de ligação bi-especìfico, e, kit | |
ECSP034490A (es) | Anticuerpos para la il-1b humana | |
AR016681A1 (es) | Deplecion de celulas th2; composiciones; metodos | |
BR112022013756A2 (pt) | Anticorpos anti-trem2 e métodos de uso dos mesmos | |
DK0871702T3 (da) | Cytokin betegnet Lerk-7 | |
ES2118820T3 (es) | Anticuerpos monoclonales para receptores de factores de celulas pluripotentes. | |
DE69406423T2 (de) | Methode zum überbringen von agenzien an zielzellen | |
AR064801A1 (es) | Anticuerpo especifico prlr (receptor de prolactina) y sus usos | |
BRPI0820885B8 (pt) | "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)". | |
BRPI0814343A2 (pt) | Materiais e métodos para a seleção da sexagem do esperma | |
DE69729307D1 (de) | Cyanidinzusammensetzungen und deren therapeutische und diagnostische verwendungen | |
ES2194024T3 (es) | Una proteina de de superficie celular, denominada proteina rib, que confiere inmunidad a muchas cepas de estreptococos del grupo b; procedimiento para purificar la proteina, kit de reactivos y composicion farmaceutica. | |
BR0116686A (pt) | Anticorpos anti-cd28 silenciados e uso dos mesmos | |
ATE132162T1 (de) | Humane gammainterferonantagonisten | |
ATE202117T1 (de) | Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma | |
PT1047449E (pt) | Composicoes imunologicas e metodos de utilizacao para alterar transitoriamente a mielina do sistema nervoso central mamifero para promover a regeneracao neuronal | |
ATE215598T1 (de) | Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen | |
AR023904A1 (es) | Anticuerpos para el antigeno de las celulas dendriticas y sus usos | |
ZA9710964B (en) | Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I | |
ES2112211B1 (es) | Procedimiento para el estudio del ciclo celular de subpoblaciones de celulas presentes en muestras celulares heterogeneas. | |
ES2159763T3 (es) | (eter)sulfatos de alcoholes grasos con comportamiento mejorado en frio. | |
AR037216A1 (es) | Anticuerpos monoclonales antinucleares de hcv | |
ES1010307U (es) | Poste municipal. | |
ES1024968U (es) | Teja perfeccionada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |